Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Huguet, Françoise  [Clear All Filters]
2014
Huguet F, Leguay T, Raffoux E, Rousselot P, Vey N, Pigneux A, Ifrah N, Dombret H. Clofarabine for the treatment of Adult Acute Lymphoid Leukemia A review article by the GRAALL intergroup. Leuk Lymphoma. 2014:1-39.
Dombret H, Cluzeau T, Huguet F, Boissel N. Pediatric-Like Therapy for Adults with ALL. Curr Hematol Malig Rep. 2014.
2015
Lepretre S, Touzart A, Vermeulin T, Picquenot J-M, Tanguy-Schmidt A, Salles G, Lamy T, Béné M-C, Raffoux E, Huguet F, et al. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study. J Clin Oncol. 2015.
2018
Bertoli S, Paubelle E, Bérard E, Saland E, Thomas X, Tavitian S, Larcher M-V, Vergez F, Sarry A, Huguet F, et al. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels and their functional as well as prognostic roles in acute myeloid leukemia. Eur J Haematol. 2018.
2022
Canali A, Vergnolle I, Bertoli S, Largeaud L, Nicolau M-L, Rieu J-B, Tavitian S, Huguet F, Picard M, Bories P, et al. Prognostic impact of unsupervised early assessment of bulk and leukemic stem cell measurable residual disease in acute myeloid leukemia. Clin Cancer Res. 2022.
2024
Chalandon Y, Rousselot P, Chevret S, Cayuela J-M, Kim R, Huguet F, Chevallier P, Graux C, Thiebaut-Bertrand A, Chantepie SP, et al. Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia. Blood. 2024.